MedTrace Logo

Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination

NCT03231137 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-07-27

No results posted yet for this study

Summary

This study was conducted to compare post-extraction augmented sockets using Atorvastatin loaded in Plasma rich in growth factors derived fibrin scaffold (PRGF/ATV) or direct application of Atorvastatin (ATV) gel or platelet rich fibrin (PRF) or (PRGF) and spontaneously healed socket (Control) both clinically and by histomorphometric analysis of formed bone quality.

Conditions

  • Alveolar Socket Preservations

Interventions

COMBINATION_PRODUCT

PRGF/ATV

Atorvastatin (ATV) loaded on plasma rich in growth factor (PRGF) Derived Fibrin Scaffold

DRUG

ATV gel

Atorvastatin gel

BIOLOGICAL

PRF

Platelet rich fibrin

BIOLOGICAL

PRGF

plasma rich in growth factor

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-16
Primary Completion
2017-03-12
Completion
2017-07-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03231137 on ClinicalTrials.gov